Atossa Therapeutics (ATOS) Prices Offering for Gross Proceeds of $20M

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. AMAT
5. META
6. NRIX
7. SPY
8. OIG
9. SUNS
10. NVDA

Go back to Atossa Therapeutics (ATOS) Prices Offering for Gross Proceeds of $20M

Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten Public Offering

December 8, 2020 9:45 PM EST

SEATTLE, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, announced today the pricing of an underwritten public offering with expected total gross proceeds of $20.0 million before deducting underwriting discounts, commissions and other offering expenses payable by the Company.

The securities offered by the Company consist of (i) 14,575,000 Units, each consisting of one share of common stock (the Common Stock), and 0.75... More